According to the U.S. Pain Foundation, chronic pain affects millions of people and can impact nearly every part of daily life – sleep, exercise, work, relationships and emotional well-being. Felicitas Huber, PhD, a WashU Medicine pain psychologist, says that treatment often requires more than medication alone.
At WashU Medicine Pain Center, specialists across disciplines collaborate to diagnose and treat how patients experience chronic pain.
Dr. Sarah Buday, WashU Medicine associate professor of anesthesiology, and Corey Woldenberg, WashU Medicine assistant professor of physical therapy and othopaedic surgery, spoke with Ladue News about interdisciplinary pain management for neuroplastic pain.
After years of debilitating neuropathy pain, D.J. Callanan found life-changing relief thanks to Dr. Chamessian who identified him as a candidate for a spinal cord stimulator.
Scientists, clinicians, and trainees gathered at the University of Health Sciences and Pharmacy in St. Louis (UHSP) this past September for the second St. Louis Translational Pain Research Forum (STL-TPRF), an event designed to foster collaboration and mentorship within the region’s growing pain research community.
WashU Medicine researchers, including Drs. Robert Gereau, Bryan Copits, and Juliet Mwirigi, were recently featured for their groundbreaking chronic pain research, advancing precision treatments and non-opioid therapies to improve patient care.
Neuroscientist Juliet Mwirigi, PhD, a postdoctoral researcher in the Department of Anesthesiology at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute (HHMI).
Burel R. Goodin, a professor of anesthesiology at WashU Medicine, has received more than $3 million from the National Institutes of Health (NIH) to support postdoctoral training.
Dr. Sarah Buday, a clinical psychologist specializing in pain psychology and an Associate Professor of Anesthesiology at WashU Medicine, explains the concept of the “October Slide”—a seasonal decline in well-being affecting people with chronic illnesses.
Dr. Nahman-Averbuch is leading two studies to help predict who is at risk of developing migraine disorder, and to identify the changes in brain connectivity and hormone levels that precede the onset of migraine headaches in adolescents.